{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:05:09Z","timestamp":1770822309039,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ygyno.2010.04.013","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T08:48:18Z","timestamp":1274518098000},"page":"116-122","source":"Crossref","is-referenced-by-count":95,"title":["Clinical validation of the Cervista\u00ae HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology"],"prefix":"10.1016","volume":"118","author":[{"given":"Mark H.","family":"Einstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco A.R.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daron G.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2010.04.013_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"10.1016\/j.ygyno.2010.04.013_bib2","series-title":"IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses","first-page":"90","year":"2005"},{"issue":"1","key":"10.1016\/j.ygyno.2010.04.013_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2006.07.031","article-title":"Clinical utility of HPV genotyping","volume":"103","author":"Meijer","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2010.04.013_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Inter J Can."},{"issue":"7","key":"10.1016\/j.ygyno.2010.04.013_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst."},{"issue":"11","key":"10.1016\/j.ygyno.2010.04.013_bib6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","article-title":"Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology","volume":"128","author":"Davey","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ygyno.2010.04.013_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ygyno.2010.04.013_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.ygyno.2010.04.013_bib9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2010.04.013_bib10","unstructured":"hc2 HPV DNA test [package insert]. Gaithersburg, MD: Digene (now Qiagen); 2007."},{"issue":"suppl 3","key":"10.1016\/j.ygyno.2010.04.013_bib11","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S1386-6532(02)00187-7","article-title":"Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail","volume":"25","author":"Poljak","year":"2002","journal-title":"J Clin Virol."},{"issue":"12","key":"10.1016\/j.ygyno.2010.04.013_bib12","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JCM.01833-07","article-title":"Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media","volume":"45","author":"Schutzbank","year":"2007","journal-title":"J Clin Microbiol."},{"issue":"8","key":"10.1016\/j.ygyno.2010.04.013_bib13","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of hybrid capture 2","volume":"46","author":"Castle","year":"2008","journal-title":"J Clin Microbiol."},{"issue":"S1","key":"10.1016\/j.ygyno.2010.04.013_bib14","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S1386-6532(09)70010-1","article-title":"Analytical performance of the investigational use only CervistaTM HPV HR test as determined by a multi-center study","volume":"45","author":"Day","year":"2009","journal-title":"J Clin Virol."},{"issue":"4","key":"10.1016\/j.ygyno.2010.04.013_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.04.013_bib16","unstructured":"Cervista\u00ae HPV HR [package insert]. Madison, WI: Hologic, Inc; 2009 (P\/N 15-3100)."},{"key":"10.1016\/j.ygyno.2010.04.013_bib17","unstructured":"GenfindTM DNA Extraction Kit [package insert]. Madison, WI: Hologic, Inc; 2009 (P\/N 15-3110). Web site: http:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/ DeviceApprovalsandClearances\/Recently-ApprovedDevices\/ucm134056.htm."},{"key":"10.1016\/j.ygyno.2010.04.013_bib18","unstructured":"Cervista\u00ae HPV 16\/18 [package insert]. Madison, WI: Hologic, Inc; 2009."},{"issue":"5","key":"10.1016\/j.ygyno.2010.04.013_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.ygyno.2010.04.013_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnci\/94.2.102","article-title":"Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)","volume":"94","author":"Sherman","year":"2002","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"10.1016\/j.ygyno.2010.04.013_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Nat Can Inst."},{"issue":"4","key":"10.1016\/j.ygyno.2010.04.013_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn","year":"2004","journal-title":"J Nat Can Inst."},{"issue":"14","key":"10.1016\/j.ygyno.2010.04.013_bib23","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.267.14.1892","article-title":"From the National Institutes of Health","volume":"267","author":"Broder","year":"1992","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2010.04.013_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1309\/RNF3C01JKADQCLKP","article-title":"The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays","volume":"127","author":"Stoler","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2010.04.013_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1309\/4DXEAFG2JXYF34N3","article-title":"A comparison of two methods to determine the presence of high-risk HPV cervical infections","volume":"130","author":"Johnson","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.ygyno.2010.04.013_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"El Ghissassi F, et al. A review of human carcinogens\u2014Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2010.04.013_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/507909","article-title":"Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer","volume":"194","author":"Wheeler","year":"2006","journal-title":"J Infect Dis."},{"issue":"16","key":"10.1016\/j.ygyno.2010.04.013_bib28","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Eng J Med."},{"key":"10.1016\/j.ygyno.2010.04.013_bib29","unstructured":"ASCCP. ASCCP: HPV genotyping clinical update. Available at: http:\/\/www.asccp.org\/pdfs\/consensus\/clinical_update_20090408.pdf. Accessed: October 1, 2009."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810003239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810003239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T03:19:02Z","timestamp":1635391142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810003239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0090825810003239"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.04.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}